{
    "success": true,
    "data": {
        "ucits": true,
        "type": "ETF",
        "leverage": false,
        "derivatives": true,
        "swaps": false,
        "inverse": false,
        "replication_method": "synthethic",
        "complex_factors": [
            "Derivatives used for replication.",
            "Counterparty Risk due to OTC derivatives",
            "Collateral Risk due to OTC derivatives",
            "Rebalancing Costs",
            "Derivative Trading Costs"
        ],
        "classification": "complex",
        "supporting_data": "The ETF is UCITS compliant but utilizes derivatives which leads to counterparty risk and collateral risk which are hard for retail investors to understand. As the derivatives are used for replication the asset is synthetically replicated rather than phsycially replicated. The risk reward profile is 6/7 which is high. The use of OTC derivatives further engenders counterparty risk which is however mitigated by UBS (Lux) Fund Solutions collateral policy. Exposure to the index through derivatives may be affected by derivative trading costs. Exposure to the index through direct replication may be affected by rebalancing costs."
    }
}